{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:27Z","timestamp":1786982667305,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s13555-024-01133-z","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T23:01:48Z","timestamp":1710975708000},"page":"1027-1037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries"],"prefix":"10.1007","volume":"14","author":[{"given":"Sergio","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Maria","family":"Piraccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Bewley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"1","key":"1133_CR1","first-page":"59","volume":"20","author":"DA Lintzeri","year":"2022","unstructured":"Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Alopecia areata\u2014current understanding and management. J Dtsch Dermatol Ges. 2022;20(1):59\u201390.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1133_CR2","first-page":"397","volume":"8","author":"AC Villasante Fricke","year":"2015","unstructured":"Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397\u2013403.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1133_CR3","doi-asserted-by":"publisher","unstructured":"Muntyanu A, Gabrielli S, Donovan J, et al. The burden of alopecia areata: a scoping review focusing on quality of life, mental health and work productivity. J Eur Acad Dermatol Venereol. 2023. https:\/\/doi.org\/10.1111\/jdv.18926.","DOI":"10.1111\/jdv.18926"},{"issue":"5","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","volume":"166","author":"AG Messenger","year":"2012","unstructured":"Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166(5):916\u201326.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1133_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","volume":"83","author":"N Meah","year":"2020","unstructured":"Meah N, Wall D, York K, Bhoyrul B, Bokhari L, Sigall DA, et al. The alopecia areata consensus of experts (ACE) study: results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol. 2020;83(1):123\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1133_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.23736\/S0392-0488.19.06458-7","volume":"154","author":"A Rossi","year":"2019","unstructured":"Rossi A, Muscianese M, Piraccini BM, Starace M, Carlesimo M, Mandel VD,\u00a0et al. Italian guidelines in diagnosis and treatment of alopecia areata. G Ital Dermatol Venereol. 2019;154(6):609\u201323.","journal-title":"G Ital Dermatol Venereol"},{"key":"1133_CR7","doi-asserted-by":"crossref","unstructured":"Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev. 2008;(2):CD004413.","DOI":"10.1002\/14651858.CD004413.pub2"},{"key":"1133_CR8","unstructured":"European Medicines Agency. Olumiant. 2017. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/olumiant. Accessed 2023 11 July."},{"key":"1133_CR9","unstructured":"Baricitnib EU SPC. https:\/\/pi.lilly.com\/us\/olumiant-uspi.pdf. Accessed 2023 11 July."},{"key":"1133_CR10","unstructured":"Administration USFAD. 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/215830s000lbl.pdf. Accessed 2023 21 Aug."},{"issue":"2","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaad.2018.07.013","volume":"80","author":"S Lee","year":"2019","unstructured":"Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466\u201377.e16.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40257-023-00805-4","volume":"24","author":"S Ly","year":"2023","unstructured":"Ly S, Manjaly P, Kamal K, et al. Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis. Am J Clin Dermatol. 2023;24(6):875\u201393.","journal-title":"Am J Clin Dermatol."},{"issue":"9","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/1346-8138.16839","volume":"50","author":"P George","year":"2023","unstructured":"George P, Jagun O, Liu Q, et al. Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database. J Dermatol. 2023;50(9):1121\u20138.","journal-title":"J Dermatol."},{"issue":"4","key":"1133_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/ced.14507","volume":"46","author":"A Egeberg","year":"2021","unstructured":"Egeberg A, Anderson S, Edson-Heredia E, Burge R. Comorbidities of alopecia areata: a population-based cohort study. Clin Exp Dermatol. 2021;46(4):651\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ced\/llac104","volume":"48","author":"S Holmes","year":"2023","unstructured":"Holmes S, Harries M, Macbeth AE, Chiu WS, de Lusignan S, Messenger AG, Tziotzios C. Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study. Clin Exp Dermatol. 2023;48(4):325\u201331.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1133_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/bjd.21055","volume":"187","author":"AE Macbeth","year":"2022","unstructured":"Macbeth AE, Holmes S, Harries M, et al. The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care. Br J Dermatol. 2022;187(1):73\u201381.","journal-title":"Br J Dermatol"},{"issue":"9","key":"1133_CR17","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1007\/s12325-021-01845-0","volume":"38","author":"M Senna","year":"2021","unstructured":"Senna M, Ko J, Tosti A, Edson-Heredia E, et al. Alopecia areata treatment patterns, healthcare resource utilization, and comorbidities in the US population using insurance claims. Adv Ther. 2021;38(9):4646\u201358.","journal-title":"Adv Ther"},{"issue":"1","key":"1133_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/1346-8138.16615","volume":"50","author":"E Campos-Alberto","year":"2023","unstructured":"Campos-Alberto E, Hirose T, Napatalung L, Ohyama M.\u00a0Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: a descriptive study using Japan medical data center claims database. J Dermatol. 2023;50(1):37\u201345.","journal-title":"J Dermatol"},{"issue":"11","key":"1133_CR19","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J.\u00a0Real-world physician and patient behaviour across countries: disease-specific programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"key":"1133_CR20","unstructured":"EPHMR. 2022 Code of Conduct. Basel: European Pharmaceutical Market Research Association. 2022. https:\/\/www.ephmra.org\/code-conduct-aer. Accessed 2023 11 July."},{"issue":"20","key":"1133_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"7","key":"1133_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","volume":"149","author":"KP Huang","year":"2013","unstructured":"Huang KP, Mullangi S, Guo Y, Qureshi AA.\u00a0Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149(7):789\u201394.","journal-title":"JAMA Dermatol"},{"key":"1133_CR23","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP.\u00a0Alopecia areata. Nat Rev Dis Primers. 2017;3:17011.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1133_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2249.2008.03679.x","volume":"153","author":"RL Rabin","year":"2008","unstructured":"Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol. 2008;153(1):19\u201330.","journal-title":"Clin Exp Immunol"},{"key":"1133_CR25","doi-asserted-by":"publisher","unstructured":"Foo JC, Redler S, Forstner AJ, et al. Exploring the overlap between alopecia areata and major depressive disorder: epidemiological and genetic perspectives. J Eur Acad Dermatol Venereol. 2023. https:\/\/doi.org\/10.1111\/jdv.18921.","DOI":"10.1111\/jdv.18921"},{"issue":"1","key":"1133_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","volume":"54","author":"RM Tr\u00fceb","year":"2018","unstructured":"Tr\u00fceb RM, Dias M. Alopecia areata: a comprehensive review of pathogenesis and management. Clin Rev Allergy Immunol. 2018;54(1):68\u201387.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1133_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s41687-020-00240-7","volume":"4","author":"NVJ Aldhouse","year":"2020","unstructured":"Aldhouse NVJ, Kitchen H, Knight S, et al. \u201c\u2018You lose your hair, what\u2019s the big deal?\u2019 I was so embarrassed, I was so self-conscious, I was so depressed:\u201d a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020;4(1):76.","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"1133_CR28","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jisp.2020.05.007","volume":"20","author":"N Mesinkovska","year":"2020","unstructured":"Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J.\u00a0Burden of illness in alopecia areata: a cross-sectional online survey study. J Investig Dermatol Symp Proc. 2020;20(1):S62\u2013S68.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"1133_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ajd.12941","volume":"60","author":"WC Cranwell","year":"2019","unstructured":"Cranwell WC, Lai VW, Photiou L, et al. Treatment of alopecia areata: an Australian expert consensus statement. Aust J Dermatol. 2019;60(2):163\u201370.","journal-title":"Aust J Dermatol"},{"issue":"5","key":"1133_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.15489","volume":"33","author":"K Phan","year":"2019","unstructured":"Phan K, Sebaratnam DF. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(5):850\u20136.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01133-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01133-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01133-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T10:02:58Z","timestamp":1714125778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01133-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01133-z","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sergio Va\u00f1\u00f3-Galv\u00e1n reports consulting fees and payment\/honoraria from Pfizer and Lilly. Alexander Egeberg reports grants from Abbvie, Danish Nathional Psoriasis Foundation, Eli Lilly, Janssen, Kgl. Hofbundtmager Aage Bangs Foundation, Novartis, Pfizer, Boehringer Ingelheim, Bristol-Myers Squibb, Almirall and Simon Spies Foundation in relation to research funding. Consulting fees from AbbVie, Almirall, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly, Galderma, Galapagos NV, Janssen, LEO Pharma, Mylan, Novartis, Pfizer, Samsung Bioepis Co., Ltd., UCB, Union Therapeutics and Horizon Therapeutics. Payment\/honoraria from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly, Galderma, Janssen, LEO Pharma, Mylan, Novartis, Pfizer, Samsung Bioepis Co., Ltd. and UCB. Support for attending congresses from Abbvie, Eli Lilly, Bristol-Myers Squibb and Janssen. Participation on a Data Safety Monitoring Board or Advisory Board from Samsung Bioepis and Horizon Therapeutics. Bianca Maria Piraccini received payment\/honoraria from Pierre fabre-Ducray, ISDIN, Legacy Healthcare, Pfizer, Almirall, Eli Lilly, Difa Cooper and Dercos-L\u2019Oreal. Simran Marwaha is an employee of Adelphi Real World. Anthony Bewley reports royalties from Wiley. Ad hoc consultancy with Abbvie, Almirall, Lilly, UCB, Pfizer, Sanofi, Leo Pharma, Galderma, Janssen, Novartis and BMS. Travel support to attend congresses from Almirall, Lilly, Janssen. Catherine Reed, Erin Johansson and Frederick Durandare employees and minor shareholders of Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines (EphMRA) and as such it did not require institutional review board (IRB)\/independent ethics committee approval. The DSP was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996. However, the AA DSP was submitted to the Western IRB for methodological review in 2019 and was granted an exemption. The DSP was conducted in compliance with the International Council for Harmonization Declaration of Helsinki. Freely given, specific and informed consent was obtained from each respondent to take part in the DSP and for the processing of their personal data. All data provided by physicians and patients were anonymized. Physicians were compensated for their participation according to fair market research rates.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}